gorodenkoff/iStock via Getty Images
Altimmune, Inc. (NASDAQ:ALT) is a great speculative biotech play to look into. That's because there are 3 data readouts expected in the 2nd half of 2022. The two more notable ones would be from a
This article is published by Terry Chrisomalis, who runs the Biotech Analysis Central pharmaceutical service on Seeking Alpha Marketplace. If you like what you read here and would like to subscribe to, I'm currently offering a two-week free trial period for subscribers to take advantage of. My service offers a deep-dive analysis of many pharmaceutical companies. The Biotech Analysis Central SA marketplace is $49 per month, but for those who sign up for the yearly plan will be able to take advantage of a 33.50% discount price of $399 per year.
